The agreement gives Biomet exclusive global distribution rights to the cranial device, as well as OsteoFab craniomxillofacial implants. The OsteoFab technology uses a type of PEEK polymer that is biocompatible to bone and an additive manufacturing process to 3-D print.
More Articles on Devices:
13 Spine Devices Receive FDA 510(k) Clearance in March
5 Thoughts on Physician-Owned Distributorships
Orthofix Names Emily Buxton as CFO
